Location: Home
  • search
  • go
  • Relate News
  • 4/29/2024WuXi Wants to Regain Client Confidence Amid Claims of IP Transfer to C...
  • 4/29/2024A US-China Pharma Drug War in the Making (Asia Times)
  • 4/29/2024Key Considerations for Entering China's Healthcare Market
  • 4/26/2024BMS and Cellares Collaboration: Navigating U.S.-China Biopharma Tensio...
  • 4/26/2024China to Further Strengthen Community Medical Services
  • 4/26/2024Recent Executive Moves
  • 4/24/2024NHC Issues Announcement on Jurisdiction of Human Genetic Resource Mana...
  • 4/24/2024Review of Leading Class 1 New Drugs by Chinese Sales Value in 2023
  • 4/23/2024Free Pricing in China for Highly Innovative Medicines (LinkedIn)
  • 4/19/2024How BIO CEO's Cozy Relationship with WuXi Soured (STAT)
  • 4/19/2024Recent Executive Moves
  • 4/17/2024China Announces the 2024 Special Rectification Plan for Illegal Activi...
  • 4/16/2024America Hits Chinese Biotech — And Its Own Drugmakers (Economist)
  • 4/15/2024China Biopharma Tracker – Q1 2024 (PharmaDJ)
  • 4/15/2024The Pharmaceutical Playbook for Asia’s Private Market (PharmExec)
  • 4/15/2024NHSA: Over 11M Chinese Benefited from Critical Illness Insurance
  • 4/12/2024PhIIC: Review of Chinese Hospital Drug Market in 2023
  • 4/12/2024Review of Chinese Online Pharmacy Drug Sales and Leading Products in 2...
  • 4/12/2024Recent Executive Moves
  • 4/11/2024NHSA's 2023 Healthcare Security Sector Development Statistical Highlig...
  • 4/11/2024NHSA Disputes Claims of a 'Dropout Wave' in China's Basic Medical Insu...
  • 4/11/2024Out-of-Area Medical Bill Settlement Jumps Nearly Fourfold After BMI S...
  • 4/11/2024Drugmakers Race to Find Alternative Suppliers as US Cracks Down on Chi...
  • 4/11/2024Geopolitics Threatens Chinese Biotechs' Hot Out-licensing Biz (Fierce ...
  • 4/10/2024Biosimilars Coming into Their Own in China, Despite Concerns (Bioworld...
  • 4/10/2024Generic Drugs Has Experienced Falling Market Share Since 2018
  • 4/9/2024Broad Measures Outlined at the 2024 Natl Conference on Rectifying Viol...
  • 4/9/2024Chinese VMS OTC Market Growth Rebounds to 7.3% in 2023
  • 4/8/2024Boehringer Ingelheim and Sino Biopharm Enter Strategic Deal to Develop...
  • 4/8/2024Over 11M Chinese Residents Benefited from Major Disease Insurance in 2...
  • Page:44/371 Total number of articles:11111: [First][<<] [42] [43] [44] [45] [46] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group